Publicacións nas que colabora con Juan Francisco Arenillas Lara (32)

2022

  1. Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders

    The Lancet Neurology, Vol. 21, Núm. 10, pp. 899-910

  2. Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance

    Neurologia, Vol. 37, Núm. 2, pp. 136-150

2021

  1. SARS-CoV-2 and Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group

    Stroke, Vol. 52, Núm. 5, pp. E117-E130

  2. Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease

    Neurologia, Vol. 36, Núm. 1, pp. 1-8

2020

  1. Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Age- and sex-specific risk profiles and in-hospital mortality in 13,932 Spanish stroke patients

    Cerebrovascular Diseases, Vol. 47, Núm. 3-4, pp. 151-164

  2. An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial

    The Lancet, Vol. 394, Núm. 10194, pp. 219-229

  3. The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism

    Translational Stroke Research, Vol. 10, Núm. 2, pp. 204-215

2018

  1. Factors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study

    Revista Clinica Espanola, Vol. 218, Núm. 7, pp. 327-335

  2. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

    The Lancet Neurology, Vol. 17, Núm. 12, pp. 1053-1060

2017

  1. Clinical profile and satisfaction with anticoagulated treatment in patients with non-valvular atrial fibrillation attended in internal medicine and neurology departments of Spain

    Revista de Neurologia, Vol. 65, Núm. 8, pp. 361-367

  2. GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke

    Stroke, Vol. 48, Núm. 5, pp. 1147-1153

2014

  1. Análisis de recursos asistenciales para el ictus en España en 2012: ¿beneficios de la Estrategia del Ictus del Sistema Nacional de Salud?

    Neurologia, Vol. 29, Núm. 7, pp. 387-396

  2. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

  3. Guía para el tratamiento del infarto cerebral agudo

    Neurologia

  4. Guía para el tratamiento preventivo del ictus isquémico y AIT (II). Recomendaciones según subtipo etiológico

    Neurologia

  5. How predictors and patterns of stroke recurrence after a TIA differ during the first year of follow-up

    Journal of Neurology, Vol. 261, Núm. 8, pp. 1614-1621

2013

  1. Guías de actuación clínica en la hemorragia intracerebral

    Neurologia

  2. Predictive value of brain and vascular imaging including intracranial vessels in transient ischaemic attack patients: External validation of the ABCD3-I score

    European Journal of Neurology, Vol. 20, Núm. 7, pp. 1088-1093

  3. Recurrent transient ischaemic attack and early risk of stroke: Data from the PROMAPA study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 84, Núm. 6, pp. 596-603